SHL Telemedicine Elects New External Director
Ticker: SHMLF · Form: 6-K · Filed: Dec 10, 2024 · CIK: 1166834
| Field | Detail |
|---|---|
| Company | Shl Telemedicine Ltd (SHMLF) |
| Form Type | 6-K |
| Filed Date | Dec 10, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, director-election
TL;DR
SHL Telemedicine just elected Orna Carni as an external director for 3 years.
AI Summary
On December 10, 2024, SHL Telemedicine Ltd. held a Special General Meeting of Shareholders where Orna Carni was elected as an external director for a three-year term. This appointment is effective from the meeting date or until her office is vacated.
Why It Matters
The election of an external director can impact corporate governance and strategic decision-making for SHL Telemedicine Ltd.
Risk Assessment
Risk Level: low — The filing is a routine corporate governance update regarding director elections.
Key Numbers
- 3 years — Director Term (Orna Carni's term as external director)
Key Players & Entities
- SHL Telemedicine Ltd. (company) — Registrant
- Orna Carni (person) — Elected External Director
- December 10, 2024 (date) — Date of Meeting and Announcement
FAQ
What was the purpose of the Special General Meeting of Shareholders held on December 10, 2024?
The sole purpose of the meeting was to elect Orna Carni as an external director of the Company.
Who was elected as an external director for SHL Telemedicine Ltd.?
Orna Carni was elected as an external director.
What is the duration of Orna Carni's term as an external director?
Orna Carni's term is for three years, commencing at the Meeting or until her office is vacated.
When did the Special General Meeting of Shareholders take place?
The meeting took place on December 10, 2024.
What is the company's principal executive office address?
The company's principal executive offices are located at 90 Yigal Alon Street, Tel Aviv 67891, Israel.
Filing Stats: 314 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2024-12-10 16:00:24
Filing Documents
- zk2432450.htm (6-K) — 10KB
- exhibit_99-1.htm (EX-99.1) — 5KB
- image00002.jpg (GRAPHIC) — 5KB
- 0001178913-24-003962.txt ( ) — 23KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-41641 SHL TELEMEDICINE LTD. (Translation of registrant's name into English) 90 Yigal Alon Street Tel Aviv 67891, Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXPLANATORY NOTE On December 10, 2024, SHL Telemedicine Ltd. (the "Company") announced that at the Special General Meeting of Shareholders of the Company held on December 10, 2024 (the "Meeting"), the sole proposal to elect Orna Carni as an external director of the Company, to serve for a term of three years commencing at the Meeting or until her office is vacated in accordance with the Company's Articles of Association or the Israel Companies Law, 5759-1999, was approved by the shareholders. A copy of the press release issued by the Company on December 10, 2024, and announcing the election of Ms. Carni is attached hereto as Exhibit 99.1 and is incorporated by reference herein. This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546), and its Registration Statement on Form 20FR12B/A filed with the Securities and Exchange Commission on March 28, 2023 (File No. 001-41641). Exhibit Description 99.1 Press release, dated December 10, 2024, announcing the results of the Special General Meeting of Shareholders. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SHL Telemedicine Ltd. By: /s/ Amir Hai Amir Hai Chief Financial Officer December 10, 2024